Bruce Johnson
Dana-Farber Cancer Insitute

Last Updated On 7/25/2020 8:52:06 AM
This is a disclosure report of the user financial relationships with for-profit health care companies.
All relationships are considered compensated unless otherwise noted. Relationships are self-held unless otherwise noted.

Employment
No Relationships to Disclose

Leadership
No Relationships to Disclose

Stock and Other Ownership Interests
No Relationships to Disclose

Honoraria
No Relationships to Disclose

Consulting or Advisory Role
Company: Novartis
Recipient: You
Company: Foundation Medicine
Recipient: You
Company: Hengrui Therapeutics
Recipient: You
Company: Daiichi Sankyo
Recipient: You
Company: Chugai Pharmaceuticals
Recipient: You
Company: Lilly
Recipient: You
Company: Checkpoint Therapeutics
Recipient: You

Speakers' Bureau
No Relationships to Disclose

Research Funding
Company: Novartis
Recipient: You
Company: Novartis
Recipient: You
Company: Toshiba
Recipient: Your Institution
Company: Novartis
Recipient: Your Institution
Company: Novartis
Recipient: Your Institution

Patents, Royalties, Other Intellectual Property
Please describe: Dana-Farber Cancer Institute
Recipient: You

Expert Testimony
No Relationships to Disclose

Travel, Accommodations, Expenses
No Relationships to Disclose

Other Relationship
No Relationships to Disclose

(OPTIONAL) Uncompensated Relationships
not answered

(OPTIONAL) Open Payments Link
not answered